Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Nokia Corporation - Managers' transactions (Ahopelto)
-
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
-
Challenged Athletes Foundation and Össur Amplify Support for Athletes with Limb Loss and Limb Differences with 115 New Grants and Mobility Clinics Offered Nationwide
-
Caisse Française de Financement Local: EMTN 2024-5
-
Execution of Definitive Agreement to Acquire up to 67% of Giraffe Energy – Expansion of Orange Basin Platform in Namibia & Creation of Community Trust
-
FFW Corporation Announces Earnings for the Quarter and Year to Date Ended March 31, 2024
-
NMDP to Present New Stem Cell Transplantation Data at the 2024 American Society of Clinical Oncology Annual Meeting
-
Landsbankinn hf.: Financial results for Q1 2024 to be published 2 May 2024
-
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Luna Innovations Incorporated with Losses to Contact the Firm
-
Diffblue Launches GitHub Actions Integration for AI-Powered Autonomous Unit Testing
-
Invitation to the presentation of ALK’s first quarter results on Friday 3 May 2024
-
Class 1 Nickel Updates Resource Estimate on High-Grade Alexo South Nickel Sulphide Deposit – Significant Increases in Indicated and Inferred Resources Over the 2020 Estimate
-
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
-
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
-
Pixalate Releases Top 100 Connected TV (CTV) Bundle ID Rankings For Global Open Programmatic Advertising on Roku, Amazon Fire TV, Samsung Smart TV, and Apple TV in March 2024
-
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Evolv Technologies Holdings, Inc. with Losses to Contact the Firm
-
Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers
-
Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers
-
Granite Creek Announces Investment in The District Communications Group (DCG)
-
Fly Play hf.: Increase of share capital
-
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Fulcrum GT Renews Its Commitment to Els for Autism Foundation
-
Meet Our Nation’s Next Generation of Leaders, Volunteer at FBLA
-
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advance
-
Blue Island Homes Chosen as Exclusive Listing Brokers for Ocean Watch at Harbor Pointe: A Premier Gated Waterfront Living Experience in Freeport, New York
-
Juniata Valley Financial Corp. Announces Results for the Quarter Ended March 31, 2024
-
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
-
Volvo Trucks North America Continues ‘Toward Zero’ by Fueling All New Trucks with HVO at the New River Valley Plant
-
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
-
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Media Advisory: Day of Mourning 2024 - CLC Executive Vice-President Larry Rousseau to attend Regina event
-
The CORE closes complaint regarding GobiMin Inc.’s alleged use of Uyghur forced labour in China
-
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
-
TransPerfect Media Acquires Content Lab to Expand Studio Presence in Africa
-
Habitat for Humanity Canada announces new President and CEO
-
ML Tech’s Digital Asset Market Neutral Opportunities Fund Reaches Milestone of Six Months of Live Trading
-
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
-
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
-
MAKE, Casper Partners With D3 To Apply For .cspr Top-Level Domain
-
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
-
CareSource names Fred A. Schulz Chief Operating Officer
-
Canon Solutions America’s University Inkjet Program Marks Five Years of Providing Students Real-World Experience
-
VenHub Advisory Board Welcomes Seasoned Oil and Gas Industry Leader, Jeffrey Rubin
-
inriver Unveils Transformative Product Innovations to Drive Efficiency, Scalability and Compliance
-
Immunocore announces upcoming presentation and posters at ASCO 2024
-
Director/PDMR Shareholding
-
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
